VentSafe, Inc.
Biotechnology company · San Francisco, California, United States
VentSafe, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2023. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $579,289 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $20,000 sold in a notice filed in 2023.
VentSafe at a glance
What does VentSafe do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $579,289 in total (2024). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $20,000 sold (2023).
Frequently asked questions about VentSafe
Where is VentSafe headquartered?
VentSafe, Inc. is headquartered in San Francisco, California, United States.
What does VentSafe do?
VentSafe, Inc. is a biotechnology company.
When was VentSafe founded?
The earliest incorporation on record for VentSafe, Inc. is in 2023, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences